- What we do
-
-
Routes of delivery
- Oral
- Nasal
- Nose to Brain
- Pulmonary
- Parenteral
-
Development stage
- Pre-clinical
- Phase I to Phase II
- Phase III - Commercial
Our Approach
- Selecting Your CDMO Partner
- Project Management
-
- About us
-
-
A CDMO like no other
- About Us
- Our Facilities
- Our History
- Awards and Achievements
-
Leadership Expertise
- Executive Leadership Team
- Board of Directors
- Careers
-
-
- Resources
- Events
- Contact
Speakers:

Dr. Richard Johnson
Chief Scientific Officer
Dr Richard Johnson is the Founding Director and Chief Scientific Officer at Upperton Pharma Solutions, a UK-based Contract, Development and Manufacturing Organisation (CDMO) and graduated from Warwick University with a PhD Biochemistry. In 1994 he was part of a management buy-out team that founded Andaris Ltd, a research and development company exploiting the use of spray drying technology in the fields of diagnostic imaging and drug delivery. In 1999, Dr Johnson founded Upperton and has overseen significant growth and expansion over the past 25 years, specialising in spray drying and nasal drug development.

Dr. Jordan Potts
Senior Development Scientist I
Jordan is a Senior Development Scientist I at Upperton. He holds an integrated Masters degree in Biomedical Sciences from Leeds Beckett University, alongside a PhD, Doctor of Philosophy from the University of Nottingham. With over five years of experience within CDMOs, Jordan has progressed from a Development Scientist role to Senior Development Scientist at Upperton, working in the Research & Development team. Jordan applies a science-led approach to support efficient development across a large range of pharmaceutical and analytical techniques.
Let’s continue the conversation.
Set up a technical call with our experts below to learn more.